Rhythm Pharmaceuticals Announces Appointment of David Meeker, M.D., as Chief Executive Officer

NEXT STORY
iCAD Appoints Jeffrey Sirek as Senior Vice President and General Manager of Xoft
PREV STORY
Synairgen announces positive results from trial of SNG001 in hospitalised COVID-19 patients
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Cytori Reports Q2 2018 Business and Financial Results

SAN DIEGO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ: CYTX) (“Cytori” or ...

author_avatar
NASDAQ Market News

AIT Therapeutics Reports Second Quarter 2017 Financial Results

REHOVOT, Israel and NEW YORK, Aug. 11, 2017 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. ...

author_avatar
NASDAQ Market News

Myriad Genetics Announces Four Presentations at the 2018 American College of Rheumatology Annual Meeting

SALT LAKE CITY, Oct. 03, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), ...

author_avatar
NASDAQ Market News